Zobrazeno 1 - 10
of 580
pro vyhledávání: '"CSU"'
Publikováno v:
CSU Digital S.A MarketLine Company Profile. 12/12/2023, p1-12. 13p.
Publikováno v:
CSU Digital S.A MarketLine Company Profile. 11/18/2022, p1-13. 14p.
Publikováno v:
CSU Cardsystem S.A. MarketLine Company Profile. 2/3/2022, p1-13. 13p.
Publikováno v:
CSU Cardsystem S.A. MarketLine Company Profile. 12/9/2021, p1-13. 13p.
Publikováno v:
CSU Cardsystem S.A. MarketLine Company Profile. 12/25/2020, p1-16. 16p.
Publikováno v:
Indian Journal of Dermatology, Vol 69, Iss 5, Pp 367-370 (2024)
Backgrounds A large proportion of patients with chronic spontaneous urticaria (CSU) are resistant to a standard dose of antihistamine. Acknowledged biomarkers for identifying these patients have not been determined. The neutrophil/lymphocyte ratio (N
Externí odkaz:
https://doaj.org/article/a0c59cd468b94302ade2a6eadedb004e
Autor:
A. I. Egorov
Publikováno v:
Научный диалог, Vol 13, Iss 6, Pp 344-364 (2024)
This article is dedicated to the examination of the diplomatic efforts undertaken by the USSR and the Federal Republic of Germany (FRG) to ensure military-political security during the period from 1987 to 1989. It explores the factors that contribute
Externí odkaz:
https://doaj.org/article/806122ed6392425f84f77ef124d28f5a
Autor:
Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben-Shoshan, Elizabeth Laws, Jennifer Maloney, Deborah Bauer, Allen Radin, Melanie Makhija
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2427-2441 (2024)
Abstract Introduction In chronic spontaneous urticaria (CSU), interleukin (IL)-4 and IL-13 may promote mast cell activation directly via IL-4 receptor expression, or indirectly via upregulated immunoglobulin E (IgE) production. Dupilumab significantl
Externí odkaz:
https://doaj.org/article/33337bbfe64f445c8596539250ffde4d
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
BackgroundOmalizumab (OMA) was the first FDA-approved biological drug for severe chronic spontaneous urticaria (CSU), and until today is the only beneficial and truly safe one. The objectives were: To assess the prevalence of CSU patients in whom OMA
Externí odkaz:
https://doaj.org/article/02283f5d0a00426cb07f0c6dbf430f7b
Autor:
Razieh Mohammadzadeh, Razieh Nazari
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 34, Iss 233, Pp 219-224 (2024)
Background and purpose: Acinetobacter baumannii is an opportunistic pathogen that causes serious infections in hospitalized patients. It is particularly concerning due to its increasing resistance to antibiotics, making it difficult to treat. This ba
Externí odkaz:
https://doaj.org/article/1639e8dc97a7435684f517d4c738889b